Genetic testing in younger women with breast cancer may be getting more common. And that could have an effect on those women's future treatment decisions.

What if there was a way to predict which cancer patients would benefit from radiation therapy? New evidence suggests, for one type of breast cancer, there could be.

What would happen if nearly every mother around the world breastfed her babies? Great things, new evidence suggests.

Young women with invasive breast cancer are often faced with a difficult choice: whether or not to undergo chemotherapy despite its risk of infertility.

The current front-line treatment for early breast cancer, tamoxifen, may have met its match.

Nearly all postmenopausal women with early-stage HR+ breast cancer are treated with aromatase inhibitors. But these drugs can significantly compromise bone health and up the risk of fractures.

The American Cancer Society (ACS), an influential voice in cancer policy and clinical care in the US for more than 100 years, recently shifted its recommendations for breast cancer screening.

Young breast cancer patients commonly have fertility concerns, and those concerns may affect their decisions about treatment.

For most people, slimming down can lower the risk for many conditions. But, for postmenopausal women, maintaining a healthy weight may be especially important.

Although it may seem intuitive that you should get screened early and often for all types of cancers, it isn't always that simple. New breast cancer screening guidelines highlight the role of personal choice in screenings for younger women, but not all experts are in agreement.